To test the correlation between p62 mRNA levels in CAFs and cancer progression, we analyzed a public mRNA database that comprised 9 CAF samples from patients with lung adenocarcinomas [25]. This evidence concerns the gene SQSTM1 and lung adenocarcinoma.